Deal Watch: Another Delay For Roche/Spark, While FTC Ups AbbVie/Allergan Merger Scrutiny

 
• By Joseph Haas and Eleanor Malone
DealWatch_1200x675
Two big pharma mergers are being delayed by scrutiny

More from Deals

More from Business